Coronary artery bypass grafting versus percutaneous coronary intervention in complex coronary artery disease: looking beyond clinical end-points.

about

Coronary artery bypass grafting versus percutaneous coronary intervention in complex coronary artery disease: looking beyond clinical end-points.

Item

http://www.wikidata.org/entity/Q47142732

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Coronary artery bypass graftin ...... ng beyond clinical end-points.

@en

Coronary artery bypass graftin ...... ng beyond clinical end-points.

@nl

type

Item

label

Coronary artery bypass graftin ...... ng beyond clinical end-points.

@en

Coronary artery bypass graftin ...... ng beyond clinical end-points.

@nl

prefLabel

Coronary artery bypass graftin ...... ng beyond clinical end-points.

@en

Coronary artery bypass graftin ...... ng beyond clinical end-points.

@nl

P1476

Coronary artery bypass graftin ...... ng beyond clinical end-points.

@en

P2093

Aakash Garg

http://www.w3.org/2001/XMLSchema#string

Hitesh Raheja

http://www.w3.org/2001/XMLSchema#string

Marc Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.

Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.

Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease.

Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.

Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease.

Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.

2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contri

P304

491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/ATM.2017.10.05

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29299453

http://www.w3.org/2001/XMLSchema#string

P921

coronary artery bypass surgery

P932

5750294

http://www.w3.org/2001/XMLSchema#string